Akari Therapeutics Plc - Ordinary Shares, $0.000000005 par value (AKTX)

Q: What does CUSIP 00972G207 represent in this 13F holders report?

CUSIP 00972G207 is the security identifier for AKTX - Akari Therapeutics Plc - Ordinary Shares, $0.000000005 par value used to aggregate holder disclosures.

Q: How many institutions held AKTX - Akari Therapeutics Plc - Ordinary Shares, $0.000000005 par value in Q3 2023?

7 institutional investors reported AKTX - Akari Therapeutics Plc - Ordinary Shares, $0.000000005 par value for Q3 2023. Use the holders table for investor-level position and value details.

CUSIP: 00972G207

Q3 2023 13F Holders as of 30 Sep 2023

Type / Class: Equity / Ordinary Shares, $0.000000005 par value
Shares outstanding: 94,284,567,045
Total 13F shares: 123,042
Share change: +123,042
Total reported value: $486,015
Price per share: $3.95
Number of holders: 7
Value change: +$486,015
Number of buys: 7

Quarterly Holders Quick Answers

What is CUSIP 00972G207?
CUSIP 00972G207 identifies AKTX - Akari Therapeutics Plc - Ordinary Shares, $0.000000005 par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q4 2023

Recent filing periods for CUSIP 00972G207:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of AKTX - Akari Therapeutics Plc - Ordinary Shares, $0.000000005 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
SABBY MANAGEMENT, LLC	13F	Company	— class O/S missing	7,392,131	$1,256,662	—	30 Jun 2023	13F
Omnia Family Wealth, LLC	13F	Company	— class O/S missing	782,372	$133,003	—	30 Jun 2023	13F
NEA Management Company, LLC	13F	Company	— class O/S missing	452,167	$76,868	—	30 Jun 2023	13F
Cerity Partners LLC	13F	Company	— class O/S missing	322,862	$54,887	—	30 Jun 2023	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	— class O/S missing	318,250	$54,000	—	30 Jun 2023	13F
Cresset Asset Management, LLC	13F	Company	— class O/S missing	216,666	$36,833	—	30 Jun 2023	13F
LPL Financial LLC	13F	Company	— class O/S missing	134,453	$22,857	—	30 Jun 2023	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	— class O/S missing	134,046	$22,774	—	30 Jun 2023	13F
Hikari Power Ltd	13F	Company	— class O/S missing	130,821	$22,000	—	30 Jun 2023	13F
Bryn Mawr Trust Advisors, LLC	13F	Company	— class O/S missing	100,000	$17,000	—	30 Jun 2023	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	— class O/S missing	30,264	$5,141	—	30 Jun 2023	13F
UBS Group AG	13F	Company	— class O/S missing	24,463	$4,159	—	30 Jun 2023	13F
Virtu Financial LLC	13F	Company	— class O/S missing	16,437	$3,000	—	30 Jun 2023	13F
TWO SIGMA SECURITIES, LLC	13F	Company	— class O/S missing	17,613	$2,994	—	30 Jun 2023	13F
BANK OF AMERICA CORP /DE/	13F	Company	— class O/S missing	3,000	$510	—	30 Jun 2023	13F
Truvestments Capital LLC	13F	Company	— class O/S missing	1,005	$171	—	30 Jun 2023	13F

Institutional Holders of Akari Therapeutics Plc - Ordinary Shares, $0.000000005 par value (AKTX) as of Q3 2023

As of 30 Sep 2023, Akari Therapeutics Plc - Ordinary Shares, $0.000000005 par value (AKTX) was held by 7 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 123,042 shares. The largest 7 holders included Omnia Family Wealth, LLC, Cerity Partners LLC, NEA Management Company, LLC, RENAISSANCE TECHNOLOGIES LLC, BANK OF AMERICA CORP /DE/, Truvestments Capital LLC, and Cornerstone Planning Group LLC. This page lists 7 institutional shareholders reporting positions in this security for the Q3 2023 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q3 2023 vs Q4 2025 Across Filers

Q4 2025 holders

Q3 2023 holders

Holder diff

-14

Investor	Q4 2025 Shares	Q3 2023 Shares	Share Diff	Share Chg %	Q4 2025 Value $	Q3 2023 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.